Abstract
No public abstract is available from the verified source records.
Ahmad S.M. Alhamshari, Mohanad Ghonim, Mdohamed Ghonim, Abhijit Bhattaru, Chaitanya Rojulpote, Mahesh K. Vidula, Senthil Selvaraj, Paco E. Bravo
Abstract
Authors
Institutions
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF
10.1161/circulationaha.122.060402 · 2022
Diagnostic Utility of SGLT2 Inhibitors to Facilitate Myocardial Glucose Suppression During Evaluation of Myocardial Inflammation
10.1016/j.jcmg.2024.02.011 · 2024
SGLT2 Inhibitor Treatment Is Associated With Reduced Cardiac Glucose Metabolism: A Matched FDG-PET Cohort Study
10.1016/j.jacadv.2025.102016 · 2025
Effect of Immunosuppressive Therapy and Biopsy Status in Monitoring Therapy Response in Suspected Cardiac Sarcoidosis
10.1016/j.jcmg.2022.05.015 · 2022
SGLT2 Inhibition Does Not Affect Myocardial Fatty Acid Oxidation or Uptake, but Reduces Myocardial Glucose Uptake and Blood Flow in Individuals With Type 2 Diabetes: A Randomized Double-Blind, Placebo-Controlled Crossover Trial
10.2337/db20-0921 · 2021
No additional external references are available.
Provenance
crossref
Confidence 100%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
unpaywall
Confidence 95%
datacite
Confidence 0%